Episomal vectors to monitor and induce somatic hypermutation in human Burkitt-Lymphoma cell lines

被引:11
|
作者
Rückerl, F [1 ]
Busse, B [1 ]
Bachl, J [1 ]
机构
[1] GSF, Natl Res Ctr Environm & Hlth, Inst Clin Mol Biol & Tumor Genet, D-81377 Munich, Germany
关键词
somatic hypermutation; activation induced cytidine deaminase; Burkitt's lymphoma; episomal vectors; GFP reversion assay;
D O I
10.1016/j.molimm.2005.09.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Somatic hypermutation (SHM) occurs at a specific B-cell differentiation stage. during the germinal centre reaction, and provides a means to diversify and shape the antibody repertoire of the adaptive immune system. Burkitt-Lymphoma (BL) is a germinal centre derived B-cell malignancy. Presumably deregulation of the somatic hypermutation- and/or class switch recombination process causes a translocation between the myc-locus and one of the Ig-loci, which is characteristic for BL. We show here that we developed an episomal-based vector system to monitor and induce AID-dependent somatic hypel-mutation in human cell lines. Exemplarily, we utilized this system to investigate the hypermutation status of various BL cell lines. Analysis of the influence of Ig-specific cis-regulatory, elements for the mutability of a green fluorescent protein (GFP) reporter transgene revealed, that the presence of la-enhancers is required for an efficient targeting of a constitutively transcribed GFP transgene. In contrast, a transcriptional inducible GFP transgene was hypermutated by overexpression of activation-induced cytidine deaminase (AID), even in the absence of Ig-specific sequences. This observation verifies that overexpression of AID in non hypermutatingg BL cell lines as well as the expression of endogenous AID in the hypermutating BL cell line Raji can overcome the target restriction of AID. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1645 / 1652
页数:8
相关论文
共 50 条
  • [1] EPISOMAL AND INTEGRATED COPIES OF EPSTEIN-BARR-VIRUS COEXIST IN BURKITT-LYMPHOMA CELL-LINES
    DELECLUSE, HJ
    BARTNIZKE, S
    HAMMERSCHMIDT, W
    BULLERDIEK, J
    BORNKAMM, GW
    JOURNAL OF VIROLOGY, 1993, 67 (03) : 1292 - 1299
  • [2] Retroviral vectors to monitor somatic hypermutation
    Klasen, M
    Spillmann, FJX
    Lorens, JB
    Wabl, M
    JOURNAL OF IMMUNOLOGICAL METHODS, 2005, 300 (1-2) : 47 - 62
  • [3] ENHANCED EFFECT OF CYCLOPHOSPHAMIDE ON BURKITT-LYMPHOMA CELL LINES INVIVO
    FURUKAWA, M
    HUANG, CC
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1976, 153 (03): : 536 - 538
  • [4] CHARACTERIZATION OF IMMUNOGLOBULIN SECRETION BY BURKITT-LYMPHOMA (BL) CELL-LINES
    BENJAMIN, D
    MAGRATH, IT
    MAGUIRE, R
    WEISS, RB
    BLAESE, M
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 260 - 260
  • [5] CHROMOSOME-ABNORMALITIES IN JAPANESE BURKITT-LYMPHOMA CELL-LINES
    HAMASAKI, K
    ACTA MEDICA OKAYAMA, 1982, 36 (01) : 23 - 38
  • [6] INSULIN-RECEPTOR EXPRESSION IN BURKITT-LYMPHOMA CELL-LINES
    NEWMAN, JD
    HARRISON, LC
    INTERNATIONAL JOURNAL OF CANCER, 1989, 44 (03) : 467 - 473
  • [7] CELL-KINETICS IN BURKITT-LYMPHOMA
    IVERSEN, OH
    IVERSEN, U
    ZIEGLER, JL
    BLUMING, AZ
    EUROPEAN JOURNAL OF CANCER, 1974, 10 (03) : 155 - &
  • [8] METASTATIC CAPACITY OF BURKITT-LYMPHOMA CELL-LINES IN NUDE-MICE
    GURTSEVITCH, VE
    TURUSOV, VS
    LENOIR, GM
    EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY, 1992, 44 (07) : 375 - 380
  • [9] EXCHANGE OF CORRESPONDING CHROMATIDS IN CELL-LINES DERIVED FROM BURKITT-LYMPHOMA
    LARRIPA, I
    BRIEUXDESALUM, S
    MEDICINA-BUENOS AIRES, 1978, 38 (06) : 753 - 753
  • [10] Overexpression of human DNA polymerase μ (Pol μ) in a Burkitt's lymphoma cell line affects the somatic hypermutation rate
    Ruiz, JF
    Lucas, D
    García-Palomero, E
    Saez, AI
    González, MA
    Piris, MA
    Bernad, A
    Blanco, L
    NUCLEIC ACIDS RESEARCH, 2004, 32 (19) : 5861 - 5873